Hillstream BioPharma Inc

-0.0144 (-3.85%)
Company Name Stock Ticker Symbol Market Type
Hillstream BioPharma Inc HILS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0144 -3.85% 0.3601 10:07:34
Open Price Low Price High Price Close Price Prev Close
0.3527 0.3527 0.37 0.3745
more quote information »

Recent News

Date Time Source Heading
5/30/202310:02IHNWFeaturedAlarum Recorded First-Ever Positive Cashflow from Operating Activities with Record Revenues in the First Quarter of 2023
5/22/202306:01EDGARAmended Annual Report (10-k/a)
5/22/202306:01EDGARCurrent Report Filing (8-k)
5/22/202306:01EDGARQuarterly Report (10-q)
5/16/202316:16EDGARNotification That Quarterly Report Will Be Submitted Late..
5/15/202316:23EDGARInitial Statement of Beneficial Ownership (3)
5/15/202316:21EDGARCurrent Report Filing (8-k)
5/15/202308:47GLOBEHillstream BioPharma Strengthens its Board of Directors with..
5/02/202316:05GLOBEHillstream BioPharma Announces Closing of Public Offering of..
5/02/202308:47GLOBEHillstream BioPharma to Present at Upcoming May 2023..
5/01/202306:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/27/202321:50GLOBEHillstream BioPharma Announces Pricing of Public Offering
4/27/202317:07EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
4/27/202316:43EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/27/202316:00GLOBEHillstream BioPharma Announces Proposed Public Offering
4/13/202308:47GLOBEHillstream BioPharma Selects OncoBay Clinical to Advance..
4/10/202308:47GLOBEHillstream BioPharma Announces Pharmacokinetic Data of..
3/28/202308:47GLOBEHillstream BioPharma to Participate in Two Major Industry..
3/17/202317:29EDGARSecurities Registration Statement (simplified Form) (s-3)
3/16/202317:31EDGARAnnual Report (10-k)
2/28/202309:45GLOBEHillstream BioPharma to Attend the 35th Annual ROTH..
2/15/202307:11GLOBEHillstream BioPharma Regains Compliance with Nasdaq Listing..
2/14/202317:16EDGARCurrent Report Filing (8-k)
2/13/202316:15GLOBEHillstream BioPharma Provides Webcast for its R&D Day on..
2/13/202307:11GLOBEHillstream BioPharma Signs Exclusive Option Agreement with..
2/10/202307:17GLOBEIn a KRAS G12C-mutated NSCLC cell line, Calu-1, Hillstream..
2/08/202307:11GLOBEHillstream BioPharma Announces Acceptance of Abstract at..
2/06/202307:00GLOBEHillstream BioPharma to Host Virtual R&D Day to Showcase its..
1/31/202309:20APSBiotech Massively Bid Up Premarket
1/31/202307:11GLOBEHillstream BioPharma Signs an Exclusive Option Agreement to..
1/17/202311:29GLOBEHillstream BioPharma to Present at the Virtual Sidoti..
12/01/202208:47GLOBEHillstream BioPharma Announces Development of Proprietary..
11/22/202206:30GLOBEHillstream BioPharma to Present at the RHK Capital..
11/14/202206:03EDGARQuarterly Report (10-q)
10/18/202208:47GLOBEHillstream’s New Anti-Cancer Mechanism Quatramer-based..
10/06/202208:47GLOBEHillstream BioPharma, Inc. to Present at Upcoming Investor..
9/14/202208:47GLOBEHillstream BioPharma to Participate in the Fierce Biotech..
8/11/202217:23EDGARQuarterly Report (10-q)
7/08/202208:17GLOBEHillstream BioPharma to Attend the 12th Annual World Orphan..
6/27/202208:27GLOBEHillstream BioPharma Announces Collaboration with Sapien..
6/21/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:16EDGARProxy Statement (definitive) (def 14a)
6/13/202208:00GLOBEHillstream BioPharma Announces Share Repurchase Program
6/07/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202208:47GLOBEHillstream BioPharma Provides Corporate Update